Erin Maxfield

Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease

Natalia Mast, Aicha Saadane, Ana C. Valencia‐Olvera et al. · Neuropharmacology · 2017 · 100 citations · Full text

Alzheimer's Disease, Oxysterol, Biochemistry +10

CYP46A1 Activation by Efavirenz Leads to Behavioral Improvement without Significant Changes in Amyloid Plaque Load in the Brain of 5XFAD Mice

Alexey M. Petrov, Morrie Lam, Natalia Mast et al. · Neurotherapeutics · 2019 · 83 citations · Full text

Neurodegenerative Diseases, Molecular Neuroscience, Alzheimer's Disease +13

CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer’s disease

Alan J. Lerner, Steven E. Arnold, Erin Maxfield et al. · Alzheimer s Research & Therapy · 2022 · 32 citations · Full text

Fluorinated triazapentadienyl ligand supported ethyl zinc(<scp>ii</scp>) complexes: reaction with dioxygen and catalytic applications in the Tishchenko reaction

Naveen V. Kulkarni, Animesh Das, Shawn G. Ridlen et al. · Dalton Transactions · 2016 · 21 citations